Takara Bio, BioExcel Diagnostics to develop wide-coverage infectious disease detection panels

Takara Bio USA, Inc., a pioneering life science reagent and instrument company and wholly owned subsidiary of Japan-base...

October 19, 2022 | Wednesday | News
Japanese firm introduces new RNA editing technology

EditForce,  headquartered in Fukuoka, Japan, has realized the world's first RNA-editing technology that enables RNA...

October 18, 2022 | Tuesday | News
Biocon out-licenses two biosimilar assets for commercialization in Japan

Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals com...

October 17, 2022 | Monday | News
Sanofi sells manufacturing site in Japan to CDMO Adragos Pharma

Adragos Pharma, a rapidly growing pharmaceutical Contract Development and Manufacturing Organization (CDMO) base...

October 14, 2022 | Friday | News
Fujifilm to establish first Bio-CDMO site in Japan

Fujifilm Corporation has announced that it will establish the company’s first Japanese Bio-CDMO (contract developm...

October 10, 2022 | Monday | News
Japan approves CathWorks device for coronary artery disease patients

Israel-based medtech company CathWorks has announced the approval of the fourth generation CathWorks FFRangio Syste...

October 10, 2022 | Monday | News
Olympus introduces new endoscopic ultrasound processor

Olympus Corporation, a Japan-based medtech company, has announced the launch of EU-ME3, a new Endoscopic Ultrasound Proc...

October 7, 2022 | Friday | News
Eisai strengthens R&D function for injectable drug formulations in Japan

Eisai has announced that as a part of the strategic investment towards the realization of its medium-term business plan ...

October 6, 2022 | Thursday | News
DentalMonitoring expands into Japan

DentalMonitoring, the leading global provider of smart dentistry solutions, is setting foot in Japan to serve the Asian ...

October 4, 2022 | Tuesday | News
Hyperthermia system made in Japan helping cancer patients in Vietnam

Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune ...

October 3, 2022 | Monday | News
Japan approves AstraZeneca's Tezspire for severe asthma treatment

AstraZeneca’s Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in pati...

September 30, 2022 | Friday | News
Takeda strengthens healthcare systems to meet patients’ need for plasma-derived therapies

As part of their well-established partnership, the United Nations Institute for Training and Research (UNITAR) and Japan...

September 30, 2022 | Friday | News
Japan approves CAR-T therapy for relapsed or refractory multiple myeloma

US-based Legend Biotech Corporation has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) ...

September 28, 2022 | Wednesday | News
Japanese firm Olympus launches THUNDERBEAT energy device for open surgery

Olympus Corporation has announced the release of the THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open s...

September 28, 2022 | Wednesday | News
Fujifilm receives regulatory approval for latest generation Endoscopic Ultrasound

Japan-based FUJIFILM Corporation has developed a convex ultrasonic endoscope, the EG-740UT, for the upper gastrointestin...

September 29, 2022 | Thursday | News
Japan approves subcutaneous injection formulation for rheumatoid arthritis

Eisai and nippon medac Co. have obtained manufacturing and marketing approval from the Japanese Ministry of Health, Labo...

September 28, 2022 | Wednesday | News
Fujitsu, Tohoku University embark on strategic alliance for preventive healthcare

Japan-based Fujitsu and Tohoku University have announced the start of a strategic alliance to accelerate the shift towar...

September 27, 2022 | Tuesday | News
Shionogi to launch business involving brain activation through sound stimulation

Japan-based Shionogi & Co., Shionogi Healthcare & Co. and Pixie Dust Technologies, Inc. (PxDT) have entered ...

September 26, 2022 | Monday | News